|

GMMG Multiple Myeloma Registry

RECRUITINGSponsored by Prof. Dr. Hartmut Goldschmidt
Actively Recruiting
SponsorProf. Dr. Hartmut Goldschmidt
Started2022-12-08
Est. completion2027-03
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07111884

Summary

The goal of this observational study is to collect long-term clinical follow-up data on patients with multiple myeloma who participated in a therapy study of the German-Speaking Myeloma Multicenter Group (GMMG). Target variables of interest are: Overall survival, progression-free survival and follow-up time. The relevant registry data will be provided and evaluated together with the therapy study data for scientific research projects. This allows seamless documentation of patient data from the end of the trial to long-term follow-up.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Previous participation in a a therapy study of the GMMG study group

Exclusion Criteria:

* patients with organ amyloidosis at time of diagnosis

Conditions2

CancerMultiple Myeloma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.